Latest independent research from Spherix Global Insights highlights growing urgency to treat PNH with complement or factor inhibitors, shifting physician preferences, and the impact of biosimilar ...

Michael Bromberg, MD, PhD, talks with Physician’s Weekly about renal disease in patients with paroxysmal nocturnal ...

Laboratory investigations revealed persistently low peripheral blood neutrophils (0.5-0.8×10 9 /L) and platelet count (1.0-2.0×10 9 /L), as well as anemia (hemoglobin, 60-80 g/L). Read more about PNH ...

Moderate or severe anemia of sudden onset was associated ... and the acidified serum test for paroxysmal nocturnal hemoglobinuria was negative. The hemolysis appeared to be episodic, with ...

DelveInsight's "EMPAVELI Market Size, Forecast, and Market Insight Report" highlights the details around EMPAVELI, a ...

EMPAVELI's unique mechanism of targeting C3 broadens its applicability beyond PNH, including other complement-driven diseases like geographic atrophy and immune complex-mediated diseases. With ...

I am 71, and I recently saw my urologist for urinating a lot and not getting enough sleep. He performed a flow test and a ...

Anemia of chronic disease is caused by long-term underlying health conditions, such as autoimmune disorders, that affect your body’s ability to make red blood cells. If you have anemia, you have ...

China has become the first country in the world to approve Roche’s anti-complement C5 antibody crovalimab, the only treatment for the rare disorder paroxysmal nocturnal haemoglobinuria (PNH ...